PPARGC1A and type 2 diabetes mellitus: Accordingly, SR18292, a synthetic molecule, directly promotes the PGC-1α/GCN5 interaction, which improves glucose homeostasis and insulin sensitivity and, as a consequence, ameliorates T2DM [235].